DOI:
10.1055/s-00000062
Psychiatrische Praxis
LinksClose Window
References
Schmidt-Kraepelin C, Feyerabend S, Engelke C. et al.
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Eur Arch Psychiatry Clin Neurosci 2019;
DOI: 10.1007/s00406-019-01063-4.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.